As of Jul 22
| +0.77 / +1.65%|
The 5 analysts offering 12-month price forecasts for Five Prime Therapeutics Inc have a median target of 50.00, with a high estimate of 55.00 and a low estimate of 41.00. The median estimate represents a +5.57% increase from the last price of 47.36.
The current consensus among 6 polled investment analysts is to Buy stock in Five Prime Therapeutics Inc. This rating has held steady since July, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.